Alvotech (ALVO) vs Trulieve Cannabis Corp. (TRLV)

Alvotech and Trulieve Cannabis Corp. are both Drug Manufacturers Specialty & Generic companies. Trulieve Cannabis Corp. is the larger, with a market value of $2.1B against $1.8B — 1.2× the size. Alvotech grew revenue faster over the last twelve months: 364.3% against −9.09%. Trulieve Cannabis Corp. has the higher net margin (−41.2% vs −101.1%) and the higher return on invested capital (0.00% vs 0.00%). Across the 15 metrics below, Trulieve Cannabis Corp. leads on 10 and Alvotech on 5.

Valuation

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 4.60 1.98 2.08
P/B n/m 2.77 1.79
Price to free cash flow n/m 11.84 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 8.56 1.99 2.87
Earnings yield (26.12%) (22.28%) (15.94%)
Free cash flow yield (15.71%) 8.44% 0.00%

Profitability

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
Gross margin 42.71% 60.64% 53.51%
Operating margin (42.43%) 0.00% 0.00%
Net margin (101.05%) (41.22%) (2.45%)
Free cash flow margin 0.00% 22.43% 0.00%
Return on equity 0.00% (45.52%) (0.80%)
Return on assets 0.00% (17.61%) (1.67%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 364.29% (9.09%) 5.22%
EPS growth (last fiscal year) 111.49% 26.58% 42.91%
Revenue growth, 5-year CAGR — 17.76% 7.24%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
Debt to equity (6.82) 0.00 0.04
Current ratio 1.65 5.52 2.41
Net debt to EBITDA 9.71 0.11 1.01

Dividend

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ALVO TRLV Drug Manufacturers Specialty & Generic median
Market cap 1.78b 2.10b 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack